Catalyst Pharmaceuticals Inc (CPRX) — Biotechnology. Numbers-first dossier: valuation, distress risk, calibrated signal.

How we compute this

CPRXpeers & supply-chain relationships

CPRX fair-value estimate

CPRX earnings history

Qtick
Sign in
Bid — × — AskUpdated Jul 14, 2026 · 4:00 PM ETVol 15.51M · 3-mo avg 2.55M

Catalyst Pharmaceuticals Inc (CPRX)

CPRXCatalyst Pharmaceuticals Incloading…
loading…
QTick signal
+3net
2 bull / 1 bear factors · leaning
Bull 4 pts·Bear 1 pts30d
loading…
Market context—Sector read · not on fileOKBalance sheet · Safe—PCE inflation days · not on file—Knife guard · not on file
Smart entry
—
model abstained · delisted
Target exit
—
model abstained · delisted
Implied move · 1 wk
—
not on file
Chart pattern
—
not on file
Pullback risk
In line
1.00× the norm · 79% saw a ≥10% dip · 63d
Chart pattern
—
not on file
Volume vs its own 20-session averagenot on file
52-week range$0.00 – $0.00
Below high since 2015-3.3% · $32.56 high
Risk / reward—
Plan stop—
Max pain$25.00 options cluster
RSI 14not on file
Forensic flags1 review
Earnings multiple9.0× fwd · 18.2× trailing
P/E vs its own past48th pctile · 17.4× median
Free cash flow yield5.4% · of market value

Entry strategy · 10 triggers

1 of 6 evaluable
RSI 14
●
—
not on file
vs 50-day
●
—
not on file
Bollinger
●
—
not on file
VWAP 20
●
—
not on file
Entry level
●
—
not on file
Put wall
●
$30.00
2026-07-17 expiry · chain of 2026-07-14
MACD
Context●
—
not on file
RVolStatic
—
not on file
Short int.Static
6.8%
short interest below 20%
ATRStatic
—
not on file
A checklist, not odds on a return: with only 1 usable price conditions there is nothing to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
See the full case→
Next earnings
2026-08-05
in 16 sessions
Next dividend
No indicated yield
no forward dividend on file